首页> 美国卫生研究院文献>PLoS Neglected Tropical Diseases >Informal genomic surveillance of regional distribution of Salmonella Typhi genotypes and antimicrobial resistance via returning travellers
【2h】

Informal genomic surveillance of regional distribution of Salmonella Typhi genotypes and antimicrobial resistance via returning travellers

机译:返回旅行者对伤寒沙门氏菌基因型区域分布和抗菌素耐药性的非正式基因组监测

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Salmonella enterica serovar Typhi (S. Typhi) is the causative agent of typhoid fever, a systemic human infection with a burden exceeding 20 million cases each year that occurs disproportionately among children in low and middle income countries. Antimicrobial therapy is the mainstay for treatment, but resistance to multiple agents is common. Here we report genotypes and antimicrobial resistance (AMR) determinants detected from routine whole-genome sequencing (WGS) of 533 S. Typhi isolates referred to Public Health England between April 2014 and March 2017, 488 (92%) of which had accompanying patient travel information obtained via an enhanced surveillance questionnaire. The majority of cases involved S. Typhi 4.3.1 (H58) linked with travel to South Asia (59%). Travel to East and West Africa were associated with genotypes 4.3.1 and 3.3.1, respectively. Point mutations in the quinolone resistance determining region (QRDR), associated with reduced susceptibility to fluoroquinolones, were very common (85% of all cases) but the frequency varied significantly by region of travel: 95% in South Asia, 43% in East Africa, 27% in West Africa. QRDR triple mutants, resistant to ciprofloxacin, were restricted to 4.3.1 lineage II and associated with travel to India, accounting for 23% of cases reporting travel to the country. Overall 24% of isolates were MDR, however the frequency varied significantly by region and country of travel: 27% in West Africa, 52% in East Africa, 55% in Pakistan, 24% in Bangladesh, 3% in India. MDR determinants were plasmid-borne (IncHI1 PST2 plasmids) in S. Typhi 3.1.1 linked to West Africa, but in all other regions MDR was chromosomally integrated in 4.3.1 lineage I. We propose that routine WGS data from travel-associated cases in industrialised countries could serve as informal sentinel AMR genomic surveillance data for countries where WGS is not available or routinely performed.
机译:伤寒沙门氏菌(伤寒沙门氏菌)是伤寒的病原体,伤寒是一种系统性人类感染,每年负担超过2000万例,在中低收入国家的儿童中不成比例地发生。抗菌疗法是治疗的主要手段,但对多种药物的耐药性却很普遍。在这里,我们报告了2014年4月至2017年3月间转诊至英国公共卫生的533个S. Typhi分离株的常规全基因组测序(WGS)所检测到的基因型和抗菌素耐药性(AMR)决定因素,其中488(92%)伴随患者旅行通过增强的监视调查表获得的信息。大多数病例涉及伤寒沙门氏菌4.3.1(H58)与前往南亚的旅行有关(59%)。到东非和西非旅行分别与基因型4.3.1和3.3.1相关。喹诺酮耐药性决定区(QRDR)的点突变与氟喹诺酮类药物的敏感性降低相关,非常普遍(占所有病例的85%),但频率随旅行地区而异:南亚为95%,东非为43% ,西非占27%。对环丙沙星有抗药性的QRDR三重突变体仅限于4.3.1谱系II且与印度旅行有关,占报告该国旅行的病例的23%。总体上,有24%的分离物是耐多药的,但不同地区和国家/地区的发生频率差异很大:西非27%,东非52%,巴基斯坦55%,孟加拉国24%,印度3%。 MDR决定簇是在与西非相关的鼠伤寒沙门氏菌3.1.1中由质粒携带的(IncHI1 PST2质粒),但在所有其他区域,MDR都通过染色体整合到了4.3.1谱系I中。我们建议从旅行相关病例中获取常规WGS数据在工业化国家/地区,可以将其用作无法获得或无法常规执行WGS的国家/地区的非正式定点AMR基因组监测数据。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号